Cargando…

The need to apply the best therapy in heart failure – the era after PARADIGM-HF

Detalles Bibliográficos
Autor principal:	Lelonek, Malgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575206/ https://www.ncbi.nlm.nih.gov/pubmed/28883868 http://dx.doi.org/10.5114/aoms.2016.59711

Ejemplares similares

Angiotensin receptor/neprilysin inhibitor—a breakthrough in chronic heart failure therapy: summary of subanalysis on PARADIGM-HF trial findings
por: Książczyk, Marcin, et al.
Publicado: (2019)

Paradigm-HF: a Paradigm Shift in Heart Failure Treatment?
por: Correia, Luis Cláudio Lemos, et al.
Publicado: (2016)

Geographic variations in the PARADIGM-HF heart failure trial
por: Kristensen, Søren Lund, et al.
Publicado: (2016)

Drug therapy for patients with systolic heart failure after the PARADIGM-HF trial: in need of a new paradigm of LCZ696 implementation in clinical practice
por: Filippatos, Gerasimos, et al.
Publicado: (2015)

PARADIGM-HF: Have we achieved a new paradigm in the treatment of heart failure?
por: Bonow, Robert O., et al.
Publicado: (2014)

Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials
por: Wijkman, Magnus O., et al.
Publicado: (2022)

Relationship between duration of heart failure, patient characteristics, outcomes, and effect of therapy in PARADIGM‐HF
por: Yeoh, Su E., et al.
Publicado: (2020)

Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al.
por: Ramires, Felix J.A., et al.
Publicado: (2018)

Paradigm Shifts of Heart Failure Therapy: Do We Need Another Paradigm?
por: Lee, Hae-Young, et al.
Publicado: (2020)

ERA(S) protocols in the pandemic era: need of the hour
por: Bawa, Chashamjot, et al.
Publicado: (2021)

PARADIGM-HF trial: will LCZ696 change the current treatment of systolic heart failure?
por: Kaplinsky, Edgardo
Publicado: (2015)

Diuretic dosing in heart failure: more data are needed
por: De Vecchis, Renato, et al.
Publicado: (2018)

Need for paradigm shift in Research and Development approaches
por: Govindaraghavan, Suresh
Publicado: (2014)

Paradigm Shift in Stroke Prevention: Need of the Hour
por: Renjen, Pushpendra Nath
Publicado: (2017)

Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM‐HF trial
por: Bhatt, Ankeet S., et al.
Publicado: (2021)

Unexplained thrombosis of the aortic arch with distal embolization in a patient with altered fibrin clot properties
por: Ciurus, Tomasz, et al.
Publicado: (2012)

Incident Cancer in Heart Failure Patients and the Need for Additional Investigations
por: Menon, Sidharth Sunil, et al.
Publicado: (2022)

The MIS-HF in clinical practice
por: Gingele, A. J., et al.
Publicado: (2022)

Dementia‐related adverse events in PARADIGM‐HF and other trials in heart failure with reduced ejection fraction
por: Cannon, Jane A., et al.
Publicado: (2016)

In the Patients’ Best Interest: Visitors Policy and Inpatient Psychiatry Wards in the COVID-19 Era
por: Maraj, Anika, et al.
Publicado: (2021)

Exogenous Surfactant Therapy in Acute Lung Injury/Acute Respiratory Distress Syndrome: The Need for a Revised Paradigm Approach
por: Dushianthan, Ahilanandan, et al.
Publicado: (2012)

Health care service usage and costs for high-needs elderly patients with heart failure
por: Buja, Alessandra, et al.
Publicado: (2020)

Early Diagnosis of Amyloid Cardiomyopathy: Potential and Need Before the Onset of Decompensated Heart Failure
por: Moriyama, Hidenori, et al.
Publicado: (2021)

Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan
por: Sokos, George G, et al.
Publicado: (2020)

Reply: Early Recognition of Amyloid Cardiomyopathy: Potential and Need Before the Onset of Decompensated Heart Failure
por: Arora, Sameer, et al.
Publicado: (2021)

Alternative Models of Cardiac Rehabilitation Delivery Urgently Needed to Improve Access for Heart Failure Patients
por: Taylor, Rod S., et al.
Publicado: (2021)

Serum potassium in the PARADIGM‐HF trial
por: Ferreira, João Pedro, et al.
Publicado: (2020)

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
por: Docherty, Kieran F, et al.
Publicado: (2020)

Reply: Alternative Models of Cardiac Rehabilitation Delivery Urgently Needed to Improve Access for Heart Failure Patients
por: Keshvani, Neil, et al.
Publicado: (2021)

Decrease in the 30-day heart failure (HF) Rehospitalization Rate after the implementation of a HF managed protocol
por: Correa, AG, et al.
Publicado: (2009)

Heart Failure after Laboratory Confirmed Influenza Infection (FLU-HF)
por: Sin, Phyllis, et al.
Publicado: (2022)

Managing Diabetes in the Era of Financial Crisis: Need to Look Beyond the Obvious
por: Koufakis, Theocharis, et al.
Publicado: (2018)

Addressing unmet needs of gastroenterologists’ training in the post–COVID-19 era
por: Marasco, Giovanni, et al.
Publicado: (2021)

Oral and maxillofacial radiology in the era of COVID-19: what needs to be done?
por: Soltani, Parisa, et al.
Publicado: (2021)

Apprising the need for a living guideline approach in the COVID-19 era
por: Magoon, Rohan, et al.
Publicado: (2022)

The need for integrated primary and behavioral healthcare care in the post-pandemic era
por: Ulupinar, Dogukan
Publicado: (2021)

Elderly Dementia Needs Better Care in Post-COVID-19 Era
por: Chen, Lili, et al.
Publicado: (2023)

HACOR score to predict failure of non-invasive ventilation in patients with acute hypoxemic respiratory failure: When simplicity is best
por: Nair, Abhijit, et al.
Publicado: (2022)

In‐hospital therapy for worsening heart failure: black box or sweet spot?
por: Tanaka, Atsushi, et al.
Publicado: (2021)

Clinical implication of ambulatory milrinone therapy in patients with advanced heart failure
por: Nakagawa, Yuri, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q07g3pksaijprhq1uci83rcpti